Technology | 2016.05.17
Bayer and ERS Genomics announce licensing agreement for Genome Editing Patents - PR Newswire (press release)
| Bayer and ERS Genomics announce licensing agreement for Genome Editing Patents PR Newswire (press release) LEVERKUSEN, Germany and DUBLIN, May 17, 2016 /PRNewswire/ -- Bayer and ERS signed a patent license agreement whereby Bayer gains access to ERS' CRISPR-Cas9 genome- editing patents for certain cross-divisional applications in Bayer's core ... Bayer strengthens position with gene editing technology with patent license deal |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]ers-genomics-announce-licensin
